The capability of “second‐generation” precursors to act as a solvent of other precursor species, thus yielding a molten multi‐component source, has been investigated in detail. In particular, this novel approach has been applied to the MOCVD process of high quality, epitaxial LaAlO 3 thin films on SrTiO 3 (100) substrates. The adopted in‐situ strategy involves a molten mixture consisting of the La(hfa) 3 • diglyme (Hhfa = 1,1,1,5,5,5‐hexafluoro‐2,4‐pentanedione, diglyme = bis(2‐methoxyethyl)ether) precursor which acts as a solvent for the Al(acac) 3 (Hacac = acetylacetone). Thermal analyses and “in situ” Fourier transform infrared (FTIR) spectra of the gas phase proved that the molten multi‐component source possesses suitable stability during vaporization and mass transport processes. The LaAlO 3 films have smooth surfaces and are epitaxially grown.
No takes yet. Share an insight, caveat, or question.
Malandrino et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: